human
respiratori
syncyti
viru
rsv
lead
viral
caus
acut
pediatr
lower
respiratori
tract
infect
worldwid
avail
vaccin
effect
antivir
drug
gain
insight
virushost
interact
perform
genomewid
sirna
screen
express
cellular
gene
individu
knock
human
airway
epitheli
cell
follow
infect
rsv
express
green
fluoresc
protein
gfp
knockdown
express
cellular
protein
major
subunit
na
k
atpas
plasma
membran
one
strongest
inhibitori
effect
gfp
express
viral
titer
inhibit
observ
vesicular
stomat
viru
indic
rsvspecif
rather
gener
effect
form
cluster
plasma
membran
earli
follow
rsv
infect
independ
replic
depend
attach
glycoprotein
g
rsv
also
trigger
activ
result
signal
csrckinas
activ
transactiv
epiderm
growth
factor
receptor
egfr
phosphoryl
signal
activ
csrc
egfr
found
requir
effici
rsv
uptak
signal
event
downstream
egfr
culmin
format
macropinosom
extens
uptak
rsv
virion
macropinosom
begin
infect
suggest
major
rout
rsv
uptak
fusion
presum
occur
macropinosom
rather
plasma
membran
import
find
valid
primari
human
small
airway
epitheli
cell
hsaec
cell
hsaec
rsv
uptak
could
inhibit
cardioton
steroid
ouabain
digitoxigenin
deriv
rostafuroxin
bind
specif
extracellular
domain
block
rsvtrigger
egfr
phosphoryl
conclus
identifi
host
protein
essenti
macropinocyt
entri
rsv
respiratori
epitheli
cell
identifi
potenti
antirsv
drug
plo
pathogen
http
doi
rsv
continu
import
viral
caus
sever
bronchiol
pneumonia
infant
young
children
also
substanti
impact
elderli
estim
claim
live
children
five
year
age
annual
vaccin
antivir
drug
suitabl
gener
use
avail
involv
host
factor
rsv
infect
replic
well
understood
knowledg
might
lead
intervent
strategi
prevent
infect
use
genomewid
sirna
screen
knock
express
individu
cellular
gene
identifi
major
subunit
na
k
atpas
import
host
protein
rsv
entri
show
activ
rsv
result
transactiv
egfr
srckinas
activ
result
uptak
rsv
particl
host
cell
macropinocytosi
also
show
cardioton
steroid
ouabain
synthet
digitoxigenin
deriv
bind
specif
extracellular
domain
significantli
reduc
rsv
entri
taken
togeth
describ
novel
mechan
use
rsv
enter
host
cell
describ
candid
antivir
drug
block
entri
signal
requir
macropinocyt
entri
rsv
plo
pathogen
http
august
compet
interest
ml
plc
sm
coinventor
patent
applic
develop
rostafuroxin
antivir
drug
rsv
occur
unknown
remain
unknown
egfr
alon
suffici
requir
factor
initi
signal
egfr
associ
signal
somehow
physic
link
caveola
rsv
entri
gener
thought
involv
fusion
viral
envelop
plasma
membran
new
evid
suggest
either
two
addit
differ
uptak
pathway
name
egfrtrigg
macropinocytosi
clathrinmedi
endocytosi
unclear
one
involv
describ
vitro
genomewid
sirna
screen
perform
identifi
cellular
protein
presumpt
role
rsv
infect
one
protein
identifi
screen
describ
previous
anoth
protein
identifi
genbank
id
na
k
atpas
complex
locat
plasma
membran
complex
contain
addit
usual
also
also
known
fxyd
subunit
major
subunit
contain
ten
transmembran
helic
emb
protein
complex
plasma
membran
form
ion
channel
fxyd
subunit
import
ion
transport
properti
na
k
atpas
also
stabil
complex
human
express
three
addit
besid
express
profil
four
isoform
cell
typedepend
express
ubiquit
predomin
isoform
cell
minor
amount
found
cell
reduc
compar
ciliat
epitheli
cell
line
nasopharynx
bronchi
mice
human
na
k
atpas
bear
present
greater
abund
basolater
surfac
lower
abund
apic
surfac
also
readili
detect
human
alveolar
cell
includ
lumin
surfac
na
k
atpas
play
major
role
ion
transport
maintain
electrolyt
fluid
balanc
addit
subpopul
na
k
atpas
local
caveola
uniqu
engag
signal
transduct
via
subunit
na
k
atpas
bear
subunit
wellcharacter
sole
receptor
cardioton
steroid
ct
ouabain
sole
known
agonist
initi
signal
ouabain
report
human
endogen
hormonelik
agent
contribut
regul
blood
pressur
among
thing
via
signal
possess
known
cytoplasm
signal
domain
interact
cytoplasm
tail
cellular
kinas
csrc
initi
signal
confer
conform
chang
csrc
expos
kinas
domain
lead
activ
autophosphoryl
csrc
tyrosin
trigger
sever
differ
signal
pathway
lead
induct
endocytosi
one
mechan
exampl
activ
csrc
mediat
phosphoryl
activ
egfr
egfindepend
manner
induc
macropinocytosi
similar
wellcharacter
egfinduc
macropinocytosi
activ
csrc
also
trigger
signal
pathway
induc
clathrinmedi
endocytosi
incident
result
remov
na
k
atpas
plasma
membran
degrad
lysosom
result
decreas
ion
channel
activ
increas
blood
pressur
revers
synthet
digitoxigenin
deriv
call
rostafuroxin
competit
inhibit
ouabain
bind
signal
evalu
therapeut
lower
kind
hypertens
report
novel
role
signal
enabl
rsv
entri
human
airway
epitheli
cell
demonstr
rsv
induc
signal
function
enabl
cell
entri
mechan
depend
activ
csrc
egfr
also
show
signal
result
induct
macropinocytosi
appear
major
rout
uptak
rsv
cell
membran
fusion
presum
occur
macropinosom
also
provid
evid
rsvinduc
activ
signal
requir
macropinocyt
entri
rsv
plo
pathogen
http
august
signal
requir
macropinocyt
entri
rsv
plo
pathogen
http
august
fig
rsv
infect
trigger
cluster
cell
inocul
wt
rsv
moi
pfucel
cell
fix
differ
time
point
pi
pfa
permeabil
stain
green
mab
donkey
antirabbit
secondari
antibodi
rsv
f
red
detect
antirsv
f
mous
mab
antimous
secondari
antibodi
cell
nuclei
stain
dapi
blue
imag
zstack
acquir
leica
confoc
microscop
object
na
zoom
arrow
indic
exampl
coloc
rsv
f
scale
bar
b
cross
section
mark
area
rsv
h
pi
imag
fig
entir
crosssect
zyview
imag
shown
movi
scale
bar
human
respiratori
syncyti
viru
rsv
lead
viral
caus
sever
lower
respiratori
tract
infect
infant
young
children
worldwid
rsvassoci
acut
lower
respiratori
infect
children
younger
year
age
death
worldwid
annual
far
licens
rsv
vaccin
effect
antivir
drug
avail
although
number
vaccin
drug
candid
develop
understand
fundament
mechan
virushost
interact
identifi
factor
critic
rsv
infect
might
lead
develop
new
antivir
drug
rsv
singl
strand
nonseg
neg
sens
rna
genom
belong
genu
orthopneumoviru
famili
pneumovirida
within
order
mononegaviral
genom
approxim
kb
long
contain
gene
encod
protein
name
genom
order
nonstructur
protein
nucleocapsid
n
phosphoprotein
p
matrix
protein
small
hydrophob
sh
attach
g
fusion
f
glycoprotein
protein
encod
two
overlap
open
read
frame
gene
larg
polymeras
protein
l
envelop
glycoprotein
g
f
mediat
viral
attach
fusion
entri
host
cell
sh
form
ion
channel
whose
role
infect
remain
unclear
sh
g
essenti
viru
replic
immort
cell
line
g
import
effici
replic
vivo
number
host
protein
pathway
suggest
play
role
rsv
attach
entri
detail
understand
remain
elus
instanc
shown
rsv
util
lipid
raft
cholesterolrich
microdomain
cell
surfac
known
caveola
dock
platform
entri
cell
surfac
glycosaminoglycan
gag
appear
import
rsv
attach
immort
cell
line
gag
appear
present
apic
surfac
primari
epitheli
cell
may
play
import
role
vivo
g
protein
contain
motif
report
mediat
cell
attach
bind
chemokin
receptor
nucleolin
also
report
cellular
receptor
rsv
bound
f
protein
epiderm
growth
factor
receptor
egfr
signal
postul
play
role
trigger
macropinocyt
uptak
signal
occur
caveola
inhibit
cholesterol
deplet
cardioton
steroid
ouabain
digitoxigenin
deriv
inhibit
rsvtrigger
activ
prevent
rsv
entri
thu
could
serv
target
antivir
drug
develop
perform
genomewid
highthroughput
sirna
screen
express
cellular
gene
individu
knock
human
airway
epitheli
cell
three
individu
sirna
per
gene
follow
infect
recombin
rsv
express
enhanc
green
fluoresc
protein
rsvgfp
knockdown
reduc
gfp
express
h
postinfect
pi
minim
effect
cell
viabil
indic
presumpt
role
protein
rsv
replic
among
gene
strongest
effect
rsvgfp
tabl
confirm
addit
differ
sirna
three
sirna
greatest
effect
express
rsv
infect
use
experi
addit
two
differ
scrambl
sirna
neg
sirna
includ
neg
control
confirm
effici
knockdown
mrna
cell
transfect
set
five
sirna
mrna
level
express
protein
quantifi
differ
time
point
post
transfect
taqman
assay
western
blot
respect
report
rel
neg
h
pt
fig
time
cours
h
fig
h
post
transfect
pt
level
mrna
reduc
compar
neg
sirna
fig
result
reduct
protein
express
h
pt
fig
show
reduct
h
pt
fig
transfect
cell
show
visibl
cytotox
morpholog
chang
period
h
sensit
evalu
cellular
atp
reflect
cell
viabil
measur
cell
lysat
h
pt
sirna
knockdown
show
minim
reduct
cell
viabil
fig
cell
transfect
panel
sirna
target
h
later
cell
infect
rsvgfp
moi
plaqu
form
unit
pfu
cell
effici
viru
infect
replic
evalu
gfp
express
quantifi
elisa
reader
fig
flow
cytometri
fig
elisa
reader
three
sirna
reduc
amount
gfp
express
compar
neg
sirna
fig
level
reduct
substanti
given
residu
level
express
remain
greater
shown
fig
also
investig
effect
infect
vesicular
stomat
viru
express
gfp
vsvgfp
knockdown
effect
gfp
express
vsvgfp
fig
indic
reduct
gfp
express
observ
rsvgfp
specif
rsv
affect
vsv
due
gener
effect
cellular
function
analysi
cell
infect
rsvgfp
moi
pfucel
flow
cytometri
h
pi
show
knockdown
result
broad
reduct
gfp
express
infectedcel
popul
rather
reduct
number
gfpexpress
cell
fig
effect
transfect
panel
sirna
product
progeni
rsvgfp
assess
h
pi
infect
cell
collect
scrape
vortex
releas
cellassoci
viru
pellet
centrifug
viru
titer
clarifi
supernat
quantifi
plaqu
titrat
vero
cell
fig
show
knockdown
rsv
titer
reduc
compar
neg
sirna
effect
even
dramat
reduct
gfp
express
describ
fig
versu
sirna
show
strongest
effect
gfp
express
viru
product
cell
infect
wt
rsv
moi
pfucel
fix
variou
time
pi
subject
immunofluoresc
stain
rsv
f
protein
mocktreat
cell
homogen
distribut
plasma
membran
fig
top
panel
follow
infect
wt
rsv
cluster
observ
earli
min
pi
fig
second
panel
wherea
cluster
evid
uninfect
cell
fig
top
panel
time
cluster
becam
promin
numer
shown
min
h
pi
fig
third
fourth
panel
shown
timepoint
earli
rsv
replic
cycl
cluster
partial
coloc
rsv
f
protein
fig
indic
arrow
local
cluster
close
proxim
rsv
f
becam
notic
later
time
point
h
pi
fig
bottom
panel
local
cluster
close
rsv
n
protein
also
could
observ
fig
fig
coloc
f
n
suggest
rsvspecif
stain
like
reflect
envelop
virion
yet
fuse
similar
cluster
rsv
n
protein
also
observ
uvinactiv
rsv
fig
indic
stain
larg
involv
preform
protein
incom
viru
cluster
requir
transcript
complet
viral
genom
viral
rna
replic
viru
replic
crosssect
fig
zyview
movi
movi
imag
rsvinfect
cell
h
pi
indic
cluster
occur
cell
surfac
local
close
rsv
virion
given
earli
appear
cluster
independ
mrna
protein
level
quantifi
rel
quantif
mrna
total
rna
isol
revers
transcrib
quantifi
taqman
assay
valu
normal
rrna
express
mean
valu
rel
neg
sirna
assign
valu
error
bar
indic
standard
deviat
three
independ
experi
three
replic
reaction
b
western
blot
analysi
express
cell
lyse
h
pt
subject
western
blot
rabbit
monoclon
antibodi
mab
correspond
infrar
dye
goat
antirabbit
secondari
antibodi
alphatubulin
use
load
control
detect
antialphatubulin
mous
mab
infrar
dye
goat
antimous
secondari
antibodi
repres
blot
shown
c
quantif
western
blot
western
blot
analys
three
independ
experi
describ
part
b
quantifi
normal
alphatubulin
report
rel
neg
sirna
assign
valu
error
bar
indic
standard
deviat
anoth
mean
explor
earli
event
rsv
infect
investig
whether
rsv
mutant
bear
delet
sh
protein
dsh
combin
delet
sh
cell
incub
h
gfp
intens
total
area
well
cell
quantifi
scan
elisa
reader
express
rel
cell
infect
viru
transfect
sirna
neg
sirna
c
flow
cytometri
analysi
rsvgfp
express
follow
infect
rsvgfp
cell
incub
h
gfp
express
singl
live
gfp
cell
quantifi
flow
cytometri
cell
untransfect
uninfect
well
includ
refer
plot
c
show
cell
count
versu
gfp
intens
histogram
show
gfp
mfi
rel
cell
infect
viru
transfect
sirna
neg
sirna
e
titer
progeni
rsvgfp
follow
infect
rsvgfp
moi
pfucel
cell
incub
h
cell
media
harvest
togeth
materi
method
yield
rsvgfp
determin
plaqu
titrat
vero
cell
data
ad
deriv
least
three
independ
experi
shown
mean
valu
error
bar
indic
standard
deviat
statist
signific
differ
determin
oneway
analysi
varianc
dunnett
multipl
comparison
posttest
pvalu
shown
comparison
http
attach
g
glycoprotein
dshdg
retain
abil
trigger
cluster
delet
rsv
f
could
investig
abrog
infect
cell
infect
wt
rsv
rsv
dsh
rsv
dshdg
moi
pfucel
incub
h
cell
fix
permeabil
immunostain
antibodi
specif
green
rsv
n
red
fig
wt
rsv
includ
refer
show
increas
cluster
format
compar
fig
may
due
increas
moi
pfucel
compar
pfucel
rsv
dsh
viru
induc
cluster
similar
wt
rsv
indic
delet
sh
protein
seem
effect
cluster
hand
dshdg
viru
induc
cluster
viral
particl
stain
rsv
n
red
reduc
amount
much
dispers
compar
wt
rsv
dsh
viru
lack
cluster
format
dshdg
viru
suggest
rsv
g
protein
involv
trigger
cluster
cluster
respons
rsv
exposur
suggest
signal
function
might
play
role
rsv
infect
exampl
signal
cascad
result
induct
endocytosi
includ
clathrinmedi
caveolinmedi
endocytosi
macropinocytosi
could
involv
rsv
entri
known
agonist
signal
ct
ouabain
activ
nonreceptor
tyrosin
kinas
srcmediat
signal
pathway
synthet
digitoxigenin
deriv
competit
inhibitor
ouabain
inhibit
ouabain
bind
signal
therefor
test
ouabain
effect
rsv
infect
serial
dilut
ouabain
evalu
cytotox
cell
fig
select
concentr
ouabain
nm
less
reduct
cell
viabil
h
post
treatment
longest
treatment
period
studi
effect
ouabain
egfr
express
analyz
immunofluoresc
microscopi
fig
use
antibodi
specif
egfr
egfr
evalu
addit
previous
shown
import
rsv
entri
close
associ
signalosom
mocktreat
cell
egfr
homogen
membran
distribut
fig
left
column
h
treatment
ouabain
level
greatli
reduc
fig
middl
column
top
panel
presum
due
remov
cellsurfac
na
k
atpas
clathrinmedi
endocytosi
induc
signal
egfr
express
local
appear
unchang
fig
rsv
g
requir
cluster
cell
inocul
wt
rsv
rgrsvdsh
rgrsvdshdg
moi
pfucel
incub
h
cell
fix
pfa
subject
immunofluoresc
stain
describ
fig
green
detect
rabbit
mab
donkey
antirabbit
secondari
antibodi
rsv
n
red
detect
antirsv
n
mous
mab
donkey
antimous
secondari
antibodi
cell
nuclei
stain
dapi
blue
imag
zstack
acquir
leica
confoc
microscop
object
na
zoom
scale
bar
http
signal
requir
macropinocyt
entri
rsv
uninfect
cell
treat
h
either
nm
ouabain
subject
immunofluoresc
stain
green
detect
rabbit
mab
donkey
antirabbit
secondari
antibodi
egfr
red
detect
antiegfr
rat
mab
goat
antirat
secondari
antibodi
cell
nuclei
stain
dapi
blue
scale
bar
compound
present
throughout
rsv
infect
evalu
gfp
express
h
pi
fig
ii
yield
progeni
rsv
harvest
h
pi
quantifi
plaqu
assay
vero
cell
fig
method
correl
well
demonstr
reduct
rsv
replic
compound
greater
achiev
sirna
fig
ouabain
strongest
effect
reduc
viral
gfp
express
viru
yield
almost
log
compar
infect
cell
receiv
drug
correspond
reduct
observ
gfp
reduct
log
reduct
viral
yield
investig
stage
rsv
infect
inhibit
compound
time
addit
experi
perform
cell
infect
rsvgfp
moi
pfu
cell
differ
time
pi
ouabain
fig
fig
ad
cell
incub
total
h
pi
viral
gfp
express
intens
singl
live
cell
analyz
flow
cytometri
compound
strongest
inhibitori
effect
observ
inhibitor
ad
simultan
rsvgfp
h
result
reduct
gfp
express
ouabain
respect
fig
inhibit
infect
continu
diminish
almost
complet
lost
drug
ad
h
pi
result
suggest
role
earli
infect
uptak
entri
also
investig
whether
treatment
effect
cluster
note
respons
rsv
cell
pretreat
describ
visual
confoc
microscopi
treatment
appar
effect
cluster
indic
cluster
depend
signal
occur
prior
step
block
next
investig
downstream
signal
pathway
might
involv
rsv
entri
bind
ouabain
activ
csrckinas
transactiv
egfr
signal
therefor
investig
whether
csrc
activ
need
rsv
infect
done
use
two
srckinas
inhibitor
srcinhibitior
srcii
cell
pretreat
inhibitor
separ
togeth
h
use
concentr
preliminari
studi
show
noncytotox
fig
follow
infect
rsvgfp
moi
pfucel
continu
presenc
inhibitor
effici
rsv
infect
evalu
gfp
express
h
pi
treatment
fig
ii
rsv
titrat
h
pi
cell
treat
inhibitor
fig
srcinhibitor
show
modest
signific
p
reduct
gfp
intens
srcii
rel
mocktreat
infect
cell
ad
togeth
inhibitori
effect
increas
reduct
compar
mocktreat
infect
cell
rsv
titer
pfu
combin
srcinhibitor
treatment
show
signific
twotail
unpair
ttest
p
reduct
compar
mocktreat
infect
cell
data
confirm
srckinas
activ
contribut
rsv
infect
next
investig
whether
egfr
downstream
signal
partner
srckinas
made
contribut
rsv
infect
identifi
egfrspecif
sirna
reduc
egfr
express
cell
protein
level
compar
neg
egfr
knockdown
cell
infect
rsvgfp
infect
evalu
viral
gfp
intens
quantifi
elisa
reader
h
pi
fig
plaqu
titrat
h
pi
vero
cell
fig
egfr
knockdown
result
nearli
reduct
viral
gfp
express
fig
compar
neg
sirna
p
also
reduct
rsv
titer
compar
neg
sirna
p
mocktransfect
cell
p
fig
modest
consist
reduct
pfu
titer
neg
unknown
reason
henc
reduct
titer
egfr
sirna
treat
cell
significantli
lower
compar
particular
control
sirna
ns
p
note
reduct
gfp
express
highli
signific
none
sirna
effect
cell
viabil
fig
taken
togeth
data
confirm
egfr
play
role
rsv
infect
next
investig
egfr
phosphoryl
rsv
infect
describ
cell
transfect
sirna
egfr
sirna
neg
sirna
incub
h
subject
immunofluoresc
stain
green
egfr
red
describ
fig
imag
zstack
acquir
leica
confoc
microscop
object
na
zoom
scale
bar
b
c
egfr
knockdown
reduc
rsv
infect
virion
product
cell
transfect
egfrspecif
sirna
neg
sirna
h
later
infect
rsvgfp
moi
pfucel
infect
quantifi
b
gfp
signal
total
well
scan
elisa
reader
h
pi
rsv
product
assess
c
plaqu
titrat
vero
cell
h
pi
data
deriv
three
independ
experi
statist
signific
differ
determin
oneway
analysi
varianc
tukey
multiplecomparison
posttest
pvalu
signific
comparison
indic
cell
viabil
atpbas
cell
viabil
assay
celltiterglo
perform
h
pt
evalu
viabil
transfect
cell
cell
lyse
atp
concentr
determin
luciferas
activ
rel
mocktransfect
cell
measur
viabil
pretreat
ouabain
srcinhibitor
cell
infect
rsv
moi
pfucel
lysat
prepar
follow
h
incub
lysat
analyz
use
egfr
phosphoryl
array
identifi
egfr
site
phosphoryl
infect
egfr
rsvinfect
cell
phosphoryl
detect
uninfect
cell
fig
fig
wherea
sampl
show
nearli
equival
h
preinocul
coincid
treatment
cell
serum
starv
h
inocul
wt
rsv
moi
pfucel
incub
h
cell
lyse
lysat
incub
phosphospecif
egfr
antibodi
array
follow
detect
bound
egfr
biotinyl
pan
ie
univers
egfr
antibodi
follow
incub
hors
radish
peroxidaseconjug
streptavidin
visual
xray
film
raybiotech
inc
xray
film
show
repres
array
spot
egfr
correspond
pan
egfr
treatment
bd
quantif
egfr
phosphoryl
egfr
signal
three
independ
experi
two
technic
replic
quantifi
scan
normal
signal
intern
array
posit
control
pan
egfr
b
show
sirna
knockdown
sampl
report
rel
neg
sirna
rsvinfect
sampl
c
show
chemicaltr
sampl
report
rel
mocktreat
rsvinfect
sampl
control
ouabain
pretreat
cell
stimul
egf
ngml
min
egfr
signal
quantifi
statist
signific
differ
determin
oneway
analysi
varianc
dunnett
multiplecomparison
test
pvalu
indic
comparison
http
phosphoryl
anoth
member
human
egfr
famili
fig
level
rsvinfect
cell
significantli
p
reduc
sirna
knockdown
cell
averag
rel
neg
fig
phosphoryl
rsvinfect
cell
similar
neg
slightli
reduc
neg
differ
signific
p
compar
neg
consist
knockdown
signific
reduct
phosphoryl
also
observ
cell
pretreat
ouabain
srckinas
inhibitor
srcii
prior
infect
rsv
fig
ouabainand
cell
level
reduc
respect
compar
mocktreat
rsvinfect
cell
reduct
similar
observ
knockdown
confirm
lack
direct
inhibitori
effect
ouabain
egfr
cell
pretreat
ouabain
stimul
egf
min
egfinduc
phosphoryl
inde
affect
compound
compar
mocktreat
cell
fig
srckinas
inhibitor
reduc
phosphoryl
compar
mocktreat
infect
cell
fig
thu
phosphoryl
egfr
could
reduc
either
decreas
express
srcspecif
inhibitor
suggest
egfr
srckinas
serv
signal
effector
transactiv
egfr
phosphoryl
egfr
signal
known
caus
actin
rearrang
membran
ruffl
activ
endocytosi
macropinocytosi
macropinocytosi
nonspecif
fluidic
uptak
cell
surfac
initi
actin
rearrang
membran
ruffl
give
rise
larg
vesicl
call
macropinosom
limit
prior
evid
suggest
macropinocytosi
rout
rsv
uptak
present
studi
cell
infect
wt
rsv
moi
pfucel
presenc
dextran
mw
conjug
fluoresc
dye
alexa
fluor
af
fluidic
uptak
marker
differ
time
point
pi
cell
wash
fix
nuclei
counterstain
dapi
uptak
dextran
analyz
fluoresc
confoc
microscopi
cell
mockinfect
found
contain
dextranposit
vesicl
small
round
homogen
size
averag
volum
fig
top
panel
reflect
basal
level
dextran
uptak
phenotyp
chang
dramat
h
infect
wt
rsv
fig
bottom
panel
dextranposit
vesicl
much
bigger
averag
volum
irregular
shape
typic
macropinosom
induct
larg
dextranposit
vesicl
also
visibl
earlier
time
point
could
detect
earli
min
pi
becam
promin
h
pi
fig
show
rsv
infect
induc
macropinocytosi
next
cell
infect
rsv
presenc
cyan
h
pi
costain
green
rsv
n
marker
rsv
virion
red
visual
fluoresc
confoc
microscopi
previous
note
h
pi
earli
rsv
infect
n
protein
detect
would
mainli
input
viru
particl
shown
earlier
uvinactiv
viru
cluster
observ
coloc
rsv
n
protein
dextranposit
macropinosom
fig
indic
arrow
indic
rsv
inde
taken
macropinocytosi
costain
rsv
f
n
also
perform
show
protein
coloc
dextranposit
macropinosom
fig
presenc
rsv
f
suggest
rsv
detect
macropinosom
envelop
indic
fusion
releas
rsv
induc
taken
macropinocytosi
block
ouabain
macropinocytosi
assay
monitor
uptak
dextran
mw
conjug
incub
preced
serumstarv
h
rsv
induc
macropinocytosi
cell
mockinfect
infect
wt
rsv
moi
pfucel
medium
contain
cyan
h
p
cell
fix
pfa
nuclei
counterstain
dapi
blue
imag
leica
confoc
microscop
object
na
zoom
b
coloc
rsv
n
rsvinfect
cell
cell
infect
rsv
presenc
describ
incub
h
fix
pfa
permeabil
triton
subject
immunofluoresc
stain
rabbit
mab
antirsvn
mous
mab
follow
goat
antirabbit
goat
antimous
secondari
nucleocapsid
presum
occur
subsequ
intern
vesicl
rather
plasma
membran
examin
role
put
uptak
mechan
express
knock
sirna
cell
treat
ouabain
previous
describ
next
cell
infect
rsv
moi
pfucel
presenc
follow
fluoresc
confoc
microscopi
multipl
random
zstack
imag
acquir
confoc
microscopi
dextranposit
vesicl
analyz
imari
imag
softwar
determin
total
fluoresc
intens
per
vesicl
vesicl
smaller
exclud
omit
basal
level
dextran
uptak
focu
larg
vesicl
typic
macropinosom
total
intens
dextran
vesicl
larger
determin
per
field
normal
number
nuclei
express
rel
neg
cell
fig
show
dextran
uptak
increas
rsvinfect
compar
uninfectedcel
transfect
neg
fig
confirm
visual
observ
increas
uptak
fig
hand
knockdown
caus
signific
p
reduct
compar
neg
fig
ouabain
caus
evengreat
reduct
rsvinduc
macropinosom
less
compar
mocktreat
rsvinfect
cell
fig
sinc
rsv
g
suggest
import
trigger
activ
base
loss
cluster
observ
dsh
dg
mutant
describ
previous
fig
also
quantifi
macropinosom
cell
infect
wt
rsv
dshdg
rsv
mutant
show
macropinosom
format
inde
significantli
p
reduc
dshdg
viru
compar
wt
rsv
fig
consist
role
g
protein
activ
pathway
lead
macropinosom
format
signal
also
induc
clathrinmedi
endocytosi
endocyt
pathway
controversi
suggest
involv
rsv
uptak
howev
preliminari
studi
hand
use
inhibitor
clathrinmedi
endocytosi
eg
chlorpromazin
detect
effect
rsv
infect
noncytotox
concentr
fig
pursu
signal
characterist
associ
caveola
structur
integr
caveola
depend
presenc
cholesterol
cholesteroldeplet
disrupt
caveola
plasma
membran
therefor
evalu
impact
deplet
cholesterol
cell
prior
rsv
infect
done
use
methylbetacyclodextrin
mbcd
mevinolin
individu
combin
noncytotox
antibodi
zstack
acquir
leica
confoc
microscop
object
na
zoom
arrow
indic
coloc
green
rsv
n
red
cyan
vesicl
c
coloc
rsv
f
rsv
n
rsvinfect
cell
cell
infect
rsv
presenc
incub
h
fix
permeabil
describ
b
cell
subject
immunostain
rsv
f
detect
antirsv
f
mab
rsv
n
detect
allophycocyanin
apc
conjug
antirsv
n
mab
novu
biolog
llc
imag
acquisit
analysi
perform
describ
b
arrow
indic
rsv
f
green
rsv
n
red
cyan
vesicl
scale
bar
df
quantif
uptak
rsv
infect
cell
transfect
neg
sirna
incub
h
pt
inocul
wt
rsv
medium
e
cell
pretreat
ouabain
h
inocul
wt
rsv
medium
f
cell
infect
wt
rsv
rgrsv
dshdg
medium
treatment
df
cell
fix
h
pi
counterstain
dapi
zstack
acquir
leica
confoc
microscop
object
na
zoom
treatment
uptak
vesicl
greater
quantifi
describ
detail
materi
method
section
mean
valu
report
rel
rsvinfect
cell
transfect
neg
sirna
mocktreat
infect
cell
e
wt
rsvinfect
cell
f
error
bar
indic
standard
deviat
least
three
independ
experi
statist
signific
differ
determin
e
oneway
analysi
varianc
tukey
multipl
comparison
posttest
f
twotail
unpair
ttest
pvalu
shown
comparison
first
infect
cholesteroldeplet
cell
rsvgfp
found
gfp
express
h
pi
reduc
approxim
deplet
compar
control
infect
cell
fig
next
quantifi
level
rsvinduc
macropinocytosi
cholesteroldeplet
cell
uptak
larg
vesicl
rsvinfect
cell
dextran
uptak
reduc
cholesteroldeplet
treatment
signific
p
reduct
observ
combin
mbcdmevinolin
treatment
fig
phosphoryl
egfr
also
determin
rsvinfect
cell
pretreat
mbcd
mevinolin
modest
signific
two
tail
ttest
p
reduct
observ
fig
result
show
cholesterol
deplet
result
reduc
egfr
transactiv
reduc
macropinocytosi
reduc
rsv
infect
consist
caveola
site
signal
experi
describ
perform
human
airway
epitheli
cell
line
sought
confirm
major
find
use
primari
human
small
airway
epitheli
cell
hsaec
old
healthi
male
donor
sirna
transfect
knock
express
protein
compar
neg
sirna
fig
somewhat
reduct
observ
cell
follow
protocol
cell
found
knockdown
reduc
express
rsvgfp
neg
control
fig
similar
observ
cell
fig
ii
phosphoryl
egfr
also
significantli
p
reduc
hsaec
fig
similar
seen
cell
fig
iii
inhibitori
effect
ouabain
express
rsvgfp
even
stronger
hsaec
cell
fig
ic
titrat
compound
hsaec
rsvgfp
express
show
valu
lower
ie
effect
inhibit
hsaec
cell
ouabain
fig
fig
iv
rsvinduc
cluster
coloc
rsv
n
also
observ
hsaec
fig
similar
cell
fig
addit
use
haeali
cultur
model
primari
differenti
polar
mucociliari
airway
epithelium
investig
local
confirm
phenomenon
rsvinduc
cluster
cell
infect
wt
rsv
pfu
transwel
incub
h
fix
pfa
permeabil
immunostain
rsv
f
red
green
describ
cell
fig
apic
surfac
demarc
stain
factin
cyan
sinc
abund
beneath
apic
membran
provid
close
estim
apic
surfac
locat
visual
locat
threedimension
section
shown
without
fig
fig
factin
stain
mock
treat
cell
predominantli
present
basolater
surfac
cell
rel
smaller
amount
present
apic
surfac
spot
distribut
fig
left
panel
upon
infect
rsv
cluster
visibl
earli
h
pi
fig
middl
panel
becam
notic
larger
h
p
fig
right
panel
apic
seem
increas
amount
time
follow
infect
suggest
recruit
apic
surfac
cluster
mostli
visibl
close
proxim
rsv
f
observ
similar
cell
fig
confirm
rsvinduc
cluster
could
reproduc
demonstr
two
differ
primari
cell
system
present
studi
investig
host
protein
involv
rsv
infect
use
genomewid
highthroughput
sirna
screen
human
airway
cell
infect
recombin
rsv
express
gfp
knockdown
cellular
protein
provid
one
greatest
reduct
gfp
express
minim
effect
cell
viabil
major
subunit
na
k
atpas
transmembran
complex
atpas
ion
channel
also
involv
signal
transduct
studi
provid
evid
particular
signal
transduct
functioni
need
effici
rsv
infect
fig
b
effici
rsv
infect
hsaec
cell
follow
knockdown
express
use
davi
rrid
necessari
use
heterozyg
genotyp
homozyg
knockout
lethal
prewean
stage
signific
differ
viru
load
observ
mice
wildtyp
litter
mate
surpris
given
modest
reduct
express
reduc
compar
wt
litter
mate
presum
suffici
reduc
effici
rsv
infect
two
drug
ouabain
found
inhibit
rsv
infect
inhibit
rsv
infect
ouabain
achiev
subnanomolar
concentr
initi
signal
cascad
inhibitori
atpas
ion
channel
function
alter
cytosol
na
k
level
incub
ouabain
deplet
na
k
atpas
time
plasma
membran
unlik
deplet
sole
mechan
inhibit
rsv
infect
antivir
effect
ouabain
evid
even
ad
simultan
viru
inoculum
specul
mechan
inhibit
shorterterm
treatment
ouabain
involv
indic
sirna
assay
gfp
quantif
elisa
reader
fig
c
egfr
phosphoryl
hsaec
cell
follow
knockdown
express
use
sirna
fig
competit
rsv
signal
discuss
later
treatment
also
reduc
effici
rsv
infect
competit
inhibitor
ouabain
share
common
bind
site
extracellular
domain
induc
signal
inde
block
signal
respons
ouabain
rsv
drug
implic
particular
signalinga
import
effici
rsv
infect
timeofaddit
experi
indic
inhibitori
effect
ouabain
occur
earli
infect
observ
strike
phenomenon
form
cluster
plasma
membran
within
minut
follow
infect
rsv
cluster
affect
treatment
indic
cluster
depend
signal
cluster
occur
equal
effici
uvinactiv
rsv
thu
independ
transcript
complet
genom
viral
rna
replic
viru
replic
cluster
reminisc
behavior
signal
receptor
follow
ligand
bind
suggest
might
physic
interact
virion
cell
surfac
trigger
cluster
interact
sort
could
imagin
part
viral
attach
part
cellular
respons
rsv
virion
howev
unabl
detect
bind
rsv
surfac
glycoprotein
g
f
sh
variou
coimmunoprecipit
techniqu
exampl
investig
possibl
bind
use
human
lung
epitheli
cell
line
kindli
provid
uri
alon
weizmann
institut
scienc
rehovot
israel
chromosom
express
genet
fuse
yellow
fluoresc
protein
yfp
tag
cell
infect
rsv
incub
lyse
coimmunoprecipit
perform
yfpspecif
antibodi
follow
western
blot
antibodi
rsv
protein
howev
evid
pulldown
rsv
protein
also
perform
compar
coprecipit
experi
prior
lysi
cell
treat
permeabl
revers
crosslink
dithiobi
succinimidyl
propion
also
incub
rsv
virion
immobil
bead
howev
evid
bind
rsv
protein
experi
also
perform
cellbas
bind
assay
use
cell
sirnatransfect
knock
specif
cell
transfect
sirna
incub
h
detach
incub
ice
rsv
min
cell
extens
wash
incub
pool
rsv
fspecif
monoclon
antibodi
detect
possibl
bound
viru
knockdown
result
appreci
reduct
rsv
bind
thu
detect
contribut
rsv
attach
treatment
cell
heparinas
prior
rsv
exposur
remov
cell
surfac
gag
done
elimin
gagmedi
rsv
attach
also
reveal
contribut
rsv
attach
therefor
evid
stabl
bind
rsv
surfac
protein
may
interact
one
rsv
protein
occur
insuffici
stabl
detect
method
use
rsv
delet
mutant
demonstr
rsv
g
protein
requir
trigger
cluster
impli
initi
viru
attach
event
involv
g
need
initi
cluster
initi
attach
event
might
involv
direct
interact
rsv
g
although
yet
evid
alreadi
note
perhap
like
rsv
attach
earlier
event
involv
cellular
structur
attach
induc
signal
asyet
unknown
intermedi
step
cluster
signal
receptor
gener
increas
ligand
bind
signal
transduct
reduc
effect
dissoci
rate
enhanc
rebind
within
receptor
cluster
therefor
cluster
may
benefici
rsv
infect
enhanc
signal
requir
viral
uptak
hypothes
rsv
util
signal
uptak
cell
endocytosi
potenti
could
involv
variou
pathway
includ
clathrinor
caveolinmedi
endocytosi
macropinocytosi
show
rsv
infect
inde
induc
requir
signal
confirm
srckinas
activ
requir
effici
rsv
infect
also
confirm
egfr
essenti
effici
rsv
infect
previous
shown
suffici
alon
requir
upstream
activ
csrc
effici
rsv
infect
signal
respons
ouabain
result
clathrinmedi
endocytosi
uptak
destruct
na
k
atpas
clathrinmedi
endocytosi
also
controversi
suggest
involv
uptak
rsv
preliminari
experi
inhibitor
clathrinmedi
endocytosi
affect
rsv
infect
howev
found
rsv
infect
induc
high
level
macropinocytosi
macropinosom
contain
high
content
rsv
virion
previou
studi
also
suggest
role
macropinocytosi
rsv
uptak
macropinocytosi
also
induc
compon
signal
pathway
exampl
describ
phosphoryl
egfr
csrc
egfindepend
manner
lead
induct
macropinocytosi
srckinas
activ
play
import
role
macropinosom
format
traffick
synergist
enhanc
macropinocyt
induct
typic
macropinosom
form
result
extens
nonspecif
fluidic
uptak
plasma
membran
review
engulf
fluid
solid
cargo
outsid
cell
cytoplasm
vesicl
heterogen
size
larger
endocyt
vesicl
diamet
rsvinfect
cell
extens
macropinocytosi
began
earli
infect
macropinosom
format
condit
confirm
depend
upon
significantli
reduc
express
decreas
cell
treat
ouabain
deplet
cholesterol
result
decreas
format
macropinosom
consist
involv
signal
complex
caveola
addit
immunostain
reveal
coloc
rsv
f
protein
marker
viral
envelop
rsv
n
protein
marker
viral
nucleocapsid
dextran
macropinosom
support
model
rsv
virion
taken
macropinosom
membran
fusion
releas
nucleocapsid
presum
take
place
later
step
macropinocyt
uptak
although
data
provid
evid
role
macropinocyt
uptak
exclud
possibl
clathrinmedi
endocytosi
addit
mode
rsv
entri
somewhat
surpris
ouabain
inhibit
rsv
infect
shortterm
treatment
sinc
opposit
effect
signal
name
ouabain
induc
inhibit
signal
mechan
inhibit
rsv
infect
seem
straightforward
specif
blockad
rsvinduc
signal
mechan
ouabain
inhibit
rsv
infect
less
clear
sinc
ouabain
rsv
individu
induc
signal
hypothes
signal
cascad
induc
ouabain
versu
rsv
employ
signal
intermedi
outcom
exactli
ouabaininduc
signal
result
clathrinmedi
endocytosi
wherea
rsvinduc
signal
result
macropinocytosi
also
could
readili
detect
phosphoryl
egfr
follow
infect
rsv
follow
treatment
ouabain
suggest
quantit
qualit
differ
egfr
phosphoryl
thu
signal
ouabain
versu
rsv
may
involv
number
step
common
signal
transduct
pathway
suggest
ouabaininduc
signal
cascad
differ
rsv
also
compet
therebi
inhibit
signal
induc
rsv
signal
cascad
report
take
place
cholesterolrich
microdomain
call
caveola
thought
serv
region
integr
multipl
signal
pathway
concentr
signal
protein
creat
tempor
spatial
pattern
cell
regul
mani
protein
associ
signal
function
present
caveola
includ
egfr
csrc
also
describ
cholesterol
need
ouabaininduc
signal
cascad
deplet
cholesterol
reduc
recruit
csrc
therefor
reduc
signal
interestingli
report
cholesterolrich
lipid
raft
requir
dock
platform
rsv
entri
present
studi
deplet
cholesterol
mbcd
mevinolin
inde
reduc
effici
rsv
infect
consist
signal
csrc
egfr
take
place
caveola
specul
inhibitori
effect
deplet
cholesterol
could
due
disintegr
caveolar
signal
complex
number
key
observ
made
use
cell
line
reproduc
use
primari
human
small
airway
epitheli
hsaec
cultur
includ
inhibit
rsvgfp
sirna
well
ouabain
cluster
rsv
exposur
phosphoryl
egfr
also
use
differenti
haeali
cultur
confirm
cluster
rsv
infect
evalu
distribut
polar
epitheli
cell
show
strong
basolater
presenc
much
reduc
speckl
express
apic
surfac
howev
upon
rsv
infect
cluster
format
observ
apic
surfac
associ
increas
apic
amount
might
due
increas
traffick
apic
surfac
also
show
small
amount
apic
present
uninfect
cell
like
suffici
initi
signal
cascad
also
implic
provir
factor
infect
cycl
ebola
viru
coronaviru
hepat
c
viru
mammarenavirus
natur
mechan
involv
virus
remain
larg
unknown
present
studi
show
vsv
infect
inhibit
knockdown
indic
effect
specif
particular
virus
involv
gener
inhibitori
cellular
effect
ouabain
describ
antivir
properti
sever
virus
name
herp
simplex
viru
chikungunya
viru
human
immunodefici
viru
adenoviru
porcin
reproduct
respiratori
syndrom
viru
mechan
inhibit
conclus
identifi
may
ouabain
inhibit
virus
way
propos
rsv
name
compet
viru
signal
knowledg
previous
investig
antivir
activ
viru
includ
rsv
specul
might
also
inhibit
replic
virus
ouabainsensit
directli
block
signal
evalu
antihypertens
drug
phase
ii
clinic
trial
ouabainand
adducininduc
hypertens
patient
known
advers
effect
lower
blood
pressur
healthi
human
therefor
might
welltoler
antivir
drug
prevail
paradigm
viru
spread
involv
packag
releas
infect
neighbor
cell
howev
emerg
model
suggest
direct
celltocel
spread
partial
assembl
virion
nucleocapsid
inclus
bodi
via
intercellular
channel
given
differ
natur
exitentri
like
requir
differ
set
protein
mechan
specul
may
role
would
primarili
engag
mediat
uptak
extracellular
packag
virion
propos
direct
intercellular
spread
presum
occur
adjoin
cell
would
import
spreaduptak
noncontigu
cell
note
studi
describ
direct
intercellular
transmiss
use
cell
line
review
specif
among
respiratori
virus
intercellular
transmiss
primari
hae
cell
shown
measl
viru
manner
spread
respiratori
virus
includ
rsv
remain
determin
primari
differenti
haeali
system
summari
propos
model
rsv
entri
human
airway
epitheli
cell
illustr
fig
rsv
infect
activ
signal
unknown
mechan
involv
rsv
g
protein
reli
viral
transcript
genom
viru
replic
activ
lead
transactiv
egfr
requir
csrc
kinas
activ
signal
event
downstream
egfr
caus
actin
rearrang
ruffl
plasma
membran
membran
extens
engulf
fluid
rsv
larg
vesiclesth
macropinosom
rsv
taken
envelop
form
macropinosom
presum
follow
fusion
entri
host
cell
also
provid
evid
suggest
signal
occur
predominantli
cholesterolrich
domain
caveola
thu
import
effici
infect
studi
identifi
signal
new
target
develop
antirsv
drug
particular
drug
alreadi
shown
welltoler
human
specif
act
decreas
effici
infect
reduc
signal
need
entri
could
develop
antivir
drug
rsv
cell
atcc
maintain
media
atcc
manassa
va
supplement
fetal
bovin
serum
fb
thermo
scientif
atlanta
ga
lglutamin
life
technolog
grand
island
ny
vero
cell
atcc
maintain
optimem
medium
glutamaxi
life
technolog
supplement
fb
normal
primari
human
small
airway
epitheli
cell
hsaec
atcc
deriv
year
old
male
hispaniclatino
donor
lot
maintain
airway
cell
basal
medium
atcc
supplement
bronchial
epitheli
cell
growth
kit
atcc
detach
passag
use
trypsin
trypsinneutr
solut
formul
specif
primari
cell
atcc
atcc
primari
cell
passag
maximum
two
time
haeali
cultur
epiairway
obtain
mattek
corpor
ashland
cultur
airliquid
interfac
describ
manufactur
protocol
provid
mainten
medium
daili
medium
chang
recombin
virus
rsvgfp
vsvgfp
wt
rsv
genbank
access
rgrsvdsh
rgrsvdshdg
previous
describ
experi
viru
stock
purifi
discontinu
wv
sucros
gradient
describ
previous
cell
cultur
maintain
co
cell
use
experi
incub
condit
highthroughput
screen
perform
data
analyz
describ
previous
brief
sirna
ambion
silenc
select
human
genom
sirna
librari
version
fischer
scientif
human
gene
sirna
per
gene
evalu
individu
high
throughput
screen
perform
plate
total
plate
use
bravo
vprep
liquid
handler
within
biocel
autom
platform
agil
singl
sirna
pmol
ad
well
follow
serumfre
medium
contain
lipofectamin
rnaimax
mixtur
incub
min
room
temperatur
follow
addit
cell
engin
constitut
express
dsred
viabil
marker
final
transfect
mixtur
contain
cell
nm
sirna
medium
fb
cell
incub
h
rsvgfp
ad
multipl
infect
moi
pfucel
cell
incub
addit
h
cell
fix
paraformaldehyd
stain
hoechst
imag
acquir
imagexpress
micro
xl
molecular
devic
autom
microscop
analyz
associ
metaxpress
softwar
use
multi
wavelength
cell
score
analysi
modul
ambion
silenc
select
neg
control
present
screen
plate
well
median
neg
control
valu
plate
use
exposur
respiratori
epitheli
cell
rsv
trigger
activ
cluster
plasma
membran
unknown
mechan
signal
via
phosphoryl
srckinas
transactiv
egfr
phosphoryl
upon
activ
egfr
signal
caus
cytoskelet
rearrang
result
plasma
membran
ruffl
format
membran
extens
report
previous
engulf
fluid
rsv
macropinosom
note
rsv
taken
macropinosom
envelop
state
suggest
fuse
cell
surfac
fusion
releas
nucleocapsid
like
occur
within
intern
macropinosom
normal
sirna
target
gfp
use
posit
control
well
per
plate
yield
nearcomplet
elimin
cell
score
posit
gfp
median
absolut
deviat
mad
base
zscore
calcul
sirna
score
adjust
seedbas
offtarget
effect
help
depriorit
like
fals
posit
median
seedadjust
zscore
provid
tabl
sirna
transfect
knock
host
protein
egfr
cell
viabil
measur
atpbas
assay
celltiterglo
promega
madison
wi
perform
describ
manufactur
cell
white
plate
lyse
atp
concentr
determin
luciferas
activ
luciferas
light
emiss
analyz
use
synergi
elisa
reader
biotek
winooski
vt
reduct
atp
rel
control
cell
indic
reduc
viabil
hsaec
cell
plate
lyse
ld
sampl
buffer
life
technolog
aliquot
lysat
reduc
denatur
electrophores
bistri
sd
gel
life
technolog
protein
transfer
onto
pvdf
membran
use
transfer
system
life
technolog
analyz
western
blot
detect
rabbit
mab
abcam
cambridg
correspond
infrar
dyeconjug
goat
antirabbit
immunoglobulin
licor
lincoln
ne
tubulin
use
load
control
detect
antitubulin
mous
mab
infrar
dyeconjug
goat
antimous
immunoglobulin
licor
western
blot
imag
acquir
odyssey
infrar
scanner
licor
analyz
imag
studio
softwar
version
licor
band
intens
valu
normal
tubulin
report
rel
neg
transfect
cell
cell
harvest
total
rna
isol
rneasi
mini
kit
qiagen
describ
manufactur
protocol
includ
oncolumn
dnase
digest
total
rna
use
revers
transcript
oligo
dt
primer
superscript
tm
firststrand
synthesi
system
rtpcr
life
technolog
synthes
cdna
predilut
use
taqman
gene
express
analysi
rrna
normal
control
taqman
assay
reaction
analyz
fast
realtim
pcr
system
appli
biosystem
foster
citi
ca
threshold
cycl
ct
reaction
determin
sd
rq
manag
program
appli
biosystem
rel
chang
transcript
level
calcul
method
report
rel
cell
transfect
neg
sirna
rsv
gene
express
measur
use
rsvgfp
recombinantli
deriv
viru
express
enhanc
green
fluoresc
protein
egfp
addit
gene
insert
p
gene
sirna
transfect
pretreat
cell
plate
inocul
moi
pfucel
inoculum
adsorb
h
rock
platform
wash
replac
fresh
media
infect
cell
incub
h
gfp
express
quantifi
either
elisa
reader
flow
cytometri
elisa
reader
quantif
gfp
intens
infect
monolay
quantifi
area
scan
averag
gfp
intens
individu
measur
per
well
synergi
elisa
reader
biotek
intens
valu
adjust
subtract
averag
intens
mockinfect
cell
background
report
rel
neg
sirna
transfect
mocktreat
cell
infect
rsvgfp
flow
cytometrybas
gfp
quantif
cell
detach
mm
edta
stain
livedead
fixabl
dead
cell
stain
kit
life
technolog
fix
paraformaldehyd
pfa
electron
microscopi
scienc
pa
gfp
intens
singl
live
cell
analyz
canto
ii
flow
cytomet
bd
bioscienc
franklin
lake
nj
median
fluoresc
intens
mfi
gfpposit
cell
determin
report
chang
rel
neg
sirna
transfect
mocktreat
cell
infect
rsvgfp
infect
cell
monolay
scrape
media
supernat
vortex
clarifi
centrifug
x
g
snap
frozen
dryic
store
sampl
serial
dilut
vero
cell
inocul
dilut
duplic
incub
h
rock
platform
cell
overlaid
optimem
life
technolog
contain
methylcellulos
sigmaaldrich
lglutamin
fb
gentamicin
incub
day
rsv
express
gfp
plaqu
visual
directli
gfp
express
typhoon
imag
system
ge
healthcar
chicago
il
wt
rsv
plaqu
fix
icecold
methanol
immunostain
mix
three
rsv
fspecif
mous
mab
follow
infrar
dyeconjug
goat
antimous
secondari
immunoglobulin
licor
plaqu
imag
odyssey
infrar
scanner
licor
count
use
imagej
softwar
version
nih
bethesda
md
cell
seed
glass
cover
slip
plate
use
still
subconflu
immunofluoresc
microscopi
base
assay
cell
fix
paraformaldehyd
h
permeabil
sigma
aldrich
min
block
pb
contain
bovin
serum
albumin
bsa
sigma
aldrich
h
room
temperatur
antibodi
dilut
prepar
pb
contain
bsa
primari
antibodi
incub
perform
humidifi
chamber
h
follow
antibodi
rabbit
abcam
rat
antiegfr
abcam
mous
antirsvn
abcam
antirsvf
mous
mab
wash
pb
secondari
antibodi
stain
perform
respect
alexa
fluor
af
conjug
secondari
antibodi
donkey
antirabbit
goat
antirabbit
donkey
antimous
goat
antirat
simultan
stain
rsvf
rsvn
perform
conjug
primari
antibodi
specif
antirsvf
mous
mab
conjug
antibodi
label
kit
thermo
fisher
scientif
waltham
commerciallyavail
antirsv
n
mous
mab
conjug
allophycocyanin
apc
novu
biolog
littleton
co
nuclei
counterstain
nm
dapi
life
technolog
pb
min
mount
glassslid
prolong
diamond
antifad
mountant
life
technolog
immunostain
haeali
cell
perform
describ
cell
except
incub
time
primari
secondari
antibodi
extend
h
addit
cultur
stain
factin
siractin
kit
cytoskeleton
inc
denver
co
imag
acquir
leica
confoc
microscop
leica
microsystem
mannheim
germani
use
oil
immers
object
na
zoom
laser
emiss
nm
nm
dapi
excit
use
nm
diod
laser
detector
slit
configur
minim
crosstalk
channel
necessari
channel
collect
sequenti
merg
afterward
imag
process
use
leica
applic
suit
x
lasx
softwar
imari
version
bitplan
ag
zurich
switzerland
imagej
imag
haeali
cell
deconvolv
huygen
essenti
deconvolut
softwar
scientif
volum
imag
bv
hilversum
netherland
egfr
phosphoryl
array
ray
biotech
norcross
ga
use
analyz
phosphoryl
egfr
receptor
famili
array
consist
nitrocellulos
membran
spot
duplic
phosphospecif
antibodi
differ
phosphoryl
site
human
egfr
famili
plu
posit
control
antibodi
bind
egfr
irrespect
phosphoryl
cell
treat
indic
either
transfect
sirna
h
prior
pretreat
indic
chemic
compound
h
coincid
transfect
treatment
cell
serumstarv
h
infect
wt
rsv
moi
pfucel
h
cell
treat
ouabain
h
incub
medium
contain
egf
sigmaaldrich
ngml
min
control
ouabain
specif
cell
wash
twice
cold
pb
lyse
provid
lysi
buffer
contain
proteas
phosphatas
inhibitor
cocktail
protein
concentr
lysat
quantifi
bicinchonin
acid
bca
assay
thermo
fisher
scientif
lysat
contain
total
protein
use
array
array
process
describ
manufactur
brief
array
incub
dilut
lysat
h
rock
platform
wash
incub
biotinyl
pan
egfr
antibodi
follow
horseradish
peroxidaseconjug
streptavidin
luminesc
detect
xray
film
film
scan
spot
intens
quantifi
imagequ
tl
array
version
ge
healthcar
three
independ
experi
two
technic
replic
normal
intern
array
control
pan
egfr
valu
report
rel
averag
signal
neg
sirna
sirnatransfect
mocktreat
inhibitortr
rsvinfect
sampl
follow
publish
procedur
cell
cover
slip
transfect
sirna
h
treat
indic
chemic
compound
coincid
transfect
treatment
cell
serumstarv
h
cell
infect
wt
rsv
moi
pfucel
media
contain
dextran
mw
life
technolog
incub
h
wash
fix
h
pfa
coloc
experi
cell
also
stain
rsv
f
rsv
n
use
specif
antibodi
describ
nuclei
counterstain
dapi
nm
pb
min
mount
glass
slide
prolong
diamond
antifad
mountant
treatment
least
ten
random
imag
acquir
use
mark
find
function
leica
lasx
imag
acquisit
softwar
zstack
leica
confoc
microscop
leica
object
na
zoom
imag
analyz
batch
process
softwar
imari
version
bitplan
ag
dapistain
nuclei
detect
spot
count
number
cell
per
field
uptak
dextran
quantifi
use
surfac
function
imari
recogn
distinct
dextranposit
vesicl
total
intens
within
creat
surfac
volum
larger
one
field
normal
number
nuclei
per
field
valu
report
rel
neg
sirna
mock
treat
cell
infect
rsv
experi
total
least
cell
per
condit
analyz
anim
studi
approv
nih
institut
anim
care
use
committe
iacuc
anim
studi
protocol
number
lid
nation
research
council
guid
care
use
laboratori
anim
public
health
servic
polici
human
care
use
laboratori
anim
serv
guidelin
care
use
mice
studi
primari
hsaec
haeali
cell
obtain
american
type
cultur
collect
atcc
mattek
corpor
respect
cell
isol
inform
consent
conform
hipaa
standard
protect
privaci
donor
person
health
inform
research
human
cell
consid
human
subject
research
cell
publicli
avail
therefor
exempt
cfr
part
institut
review
board
irb
approv
requir
support
inform
tabl
summari
primari
sirna
screen
express
knockdown
sirna
screen
perform
transfect
cell
engin
express
dsred
viabil
marker
ambion
silenc
select
genomewid
sirna
librari
target
gene
three
independ
sirna
per
gene
evalu
individu
fortyeight
h
posttransfect
cell
infect
pfucel
rsvgfp
effect
knockdown
gfp
express
measur
h
postinfect
data
analyz
previous
describ
median
seed
correct
zscore
test
target
shown
fig
cell
viabil
atpbas
cell
viabil
assay
celltiterglo
promega
perform
h
pt
evalu
viabil
transfect
cell
cell
lyse
atp
concentr
determin
atpdepend
luciferas
activ
detect
elisa
reader
viabil
report
rel
mocktransfect
cell
assign
valu
tif
fig
cluster
induc
uvinactiv
rsv
cell
inocul
moi
pfucel
describ
fig
incub
h
uv
wt
rsv
inoculum
uvinactiv
jcm
uv
radiat
use
stratalink
uv
crosslink
agil
total
inactiv
inoculum
confirm
plaqu
titrat
vero
cell
cell
subject
immunofluoresc
stain
green
rsvn
red
counterstain
nuclei
dapi
blue
scale
bar
fig
imag
acquir
describ
